Clinical Trial Update: Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating immunogenicity and safety of a COVID-19 vaccine in people living with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Beijing 302 Hospital | Conditions: People Living With HIV, COVID-19 | Phase 4 | Status: UNKNOWN